Amyris Inc. (AMRS)

MATERIALS: CHEMICALS
SIC: INDUSTRIAL ORGANIC CHEMICALS

5885 HOLLIS STREET, SUITE 100 EMERYVILLE, CA 94608

Amyris Biotechnologies, Inc. focuses on developing and providing renewable compounds for various markets. The company is building and applying its industrial synthetic biology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide.

Data based on most recent fiscal year report
Market Cap292.604 Million Shares Outstanding43.03 Million Avg Volume2.142 Million
1-Yr BETA vs S&P TR0.455 Current Ratio0.54 Quick Ratio0.48
View SEC Filings from AMRS instead.
Q1 2018 All Institutions Hedge Funds 1
To trade AMRS now:
Filers who had this stock in their top 10: 3 2 (0.19%)
13F Filers holding this stock: 49 15 (1.42%)
Aggregate 13F shares on 03/31/2018: 11.902 Million 4.924 Million
Aggregate 13F shares on 12/31/2017: 9.627 Million 3.932 Million
Percent change: 23.63% 25.21%
Funds creating new positions: 18 10
Funds Adding to an existing position: 15 15
Funds closing out their position: 3 2
Funds reducing their position: 4 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AMRS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

95.2 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Acquired or Disposed Shares Owned Following Transaction Direct/Indirect Ownership

MELO JOHN - Director - Officer PRESIDENT AND CEO

2018-06-01 F 3,265 d 782,039 direct

CHERRY JOEL - Officer PRESIDENT OF R&D

2018-06-01 F 845 d 270,153 direct

MELO JOHN - Director - Officer PRESIDENT AND CEO

2018-05-29 A 700,000 a 785,304 direct

KELSEY NICOLE - Officer GENERAL COUNSEL AND SECRETARY

2018-05-29 A 100,000 a 121,000 direct

VALIASEK KATHLEEN - Officer CHIEF FINANCIAL OFFICER

2018-05-29 A 200,000 a 214,630 direct

CHERRY JOEL - Officer PRESIDENT OF R&D

2018-05-29 A 212,500 a 270,998 direct

ALVAREZ EDUARDO - Officer CHIEF OPERATING OFFICER

2018-05-29 A 250,000 a 320,000 direct

MELO JOHN - Director - Officer PRESIDENT AND CEO

2018-05-29 A 3,250,000 a 3,250,000 direct

KELSEY NICOLE - Officer GENERAL COUNSEL AND SECRETARY

2018-05-29 A 50,000 a 50,000 direct

VALIASEK KATHLEEN - Officer CHIEF FINANCIAL OFFICER

2018-05-29 A 100,000 a 100,000 direct

CHERRY JOEL - Officer PRESIDENT OF R&D

2018-05-29 A 37,500 a 37,500 direct

MAXWELL (MAURITIUS) PTE LTD - > 10% Owner

CAIRNHILL INVESTMENTS (MAURITIUS) PTE LTD - > 10% Owner

FULLERTON MANAGEMENT PTE LTD - > 10% Owner

TEMASEK HOLDINGS (PRIVATE) LTD - > 10% Owner

2018-05-07 S 95,162 d 3,207,423 direct

VALIASEK KATHLEEN - Officer CHIEF FINANCIAL OFFICER

2018-05-01 F 538 d 14,630 direct

MELO JOHN - Director - Officer PRESIDENT AND CEO

2018-05-01 F 5,379 d 85,304 direct

CHERRY JOEL - Officer PRESIDENT OF R&D

2018-05-01 F 2,851 d 57,785 direct

MELO JOHN - Director - Officer PRESIDENT AND CEO

2018-05-01 F 3,265 d 90,683 direct

CHERRY JOEL - Officer PRESIDENT OF R&D

2018-05-01 F 1,536 d 60,636 direct
Click here to report any possible errors with this stock listing.

Elevate your investments